168 related articles for article (PubMed ID: 35111662)
21. Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study.
Wang X; Zhu A; Wang J; Ma F; Liu J; Fan Y; Luo Y; Zhang P; Li Q; Xu B; Yuan P
Ther Adv Med Oncol; 2020; 12():1758835920925991. PubMed ID: 32518597
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma.
Lu X; Qian C
Comput Math Methods Med; 2022; 2022():1979254. PubMed ID: 35464999
[TBL] [Abstract][Full Text] [Related]
23. Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study.
Schubert CM; Rogers NL; Remsberg KE; Sun SS; Chumlea WC; Demerath EW; Czerwinski SA; Towne B; Siervogel RM
Int J Obes (Lond); 2006 Feb; 30(2):251-60. PubMed ID: 16247511
[TBL] [Abstract][Full Text] [Related]
24. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Esteva FJ; Hortobagyi GN
Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
[TBL] [Abstract][Full Text] [Related]
25. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
Ziller V; Kalder M; Albert US; Holzhauer W; Ziller M; Wagner U; Hadji P
Ann Oncol; 2009 Mar; 20(3):431-6. PubMed ID: 19150950
[TBL] [Abstract][Full Text] [Related]
26. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
Hong N; Yoon HG; Seo DH; Park S; Kim SI; Sohn JH; Rhee Y
Eur J Cancer; 2017 Sep; 82():103-114. PubMed ID: 28651157
[TBL] [Abstract][Full Text] [Related]
27. Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.
Wasan KM; Goss PE; Pritchard PH; Shepherd L; Tu D; Ingle JN
Breast Cancer Res Treat; 2012 Dec; 136(3):769-76. PubMed ID: 23089983
[TBL] [Abstract][Full Text] [Related]
28. [A case-control study on the association between serum lipid level and the risk of breast cancer].
Wei LJ; Zhang C; Zhang H; Wei X; Li SX; Liu JT; Ren XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1091-1095. PubMed ID: 28057114
[No Abstract] [Full Text] [Related]
29. Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis.
Bérczi B; Farkas N; Hegyi P; Tóth B; Csupor D; Németh B; Lukács A; Czumbel LM; Kerémi B; Kiss I; Szabó A; Varga G; Gerber G; Gyöngyi Z
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38542042
[No Abstract] [Full Text] [Related]
30. Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.
Bell LN; Nguyen AT; Li L; Desta Z; Henry NL; Hayes DF; Wolff AC; Stearns V; Storniolo AM; Flockhart DA;
J Clin Pharmacol; 2012 Dec; 52(12):1852-60. PubMed ID: 22174434
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
[TBL] [Abstract][Full Text] [Related]
32. Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole.
Skedgel C; Rayson D; Dewar R; Younis T
Breast Cancer Res Treat; 2007 Mar; 101(3):325-33. PubMed ID: 16897433
[TBL] [Abstract][Full Text] [Related]
33. The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer.
Kang YK; Wang X; Hu NL; Yue J; Si YR; Ju J; Gao SL; Yuan P
Front Oncol; 2021; 11():759595. PubMed ID: 34926260
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
Takei H; Ohsumi S; Shimozuma K; Takehara M; Suemasu K; Ohashi Y; Hozumi Y
Breast Cancer Res Treat; 2012 May; 133(1):227-36. PubMed ID: 22234519
[TBL] [Abstract][Full Text] [Related]
35. The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.
Montagnani A; Gonnelli S; Cadirni A; Caffarelli C; Del Santo K; Pieropan C; Campagna MS; Montomoli M; Petrioli R; Nuti R
Eur J Intern Med; 2008 Dec; 19(8):592-7. PubMed ID: 19046724
[TBL] [Abstract][Full Text] [Related]
36. Recommended reference values for serum lipids during early and middle pregnancy: a retrospective study from China.
Wang C; Kong L; Yang Y; Wei Y; Zhu W; Su R; Lin L; Yang H
Lipids Health Dis; 2018 Oct; 17(1):246. PubMed ID: 30382875
[TBL] [Abstract][Full Text] [Related]
37. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
[TBL] [Abstract][Full Text] [Related]
38. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
Yoo WH
J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.
Masri S; Phung S; Wang X; Chen S
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):277-82. PubMed ID: 19897035
[TBL] [Abstract][Full Text] [Related]
40. Association between early pregnancy vitamin D status and changes in serum lipid profiles throughout pregnancy.
Lepsch J; Eshriqui I; Farias DR; Vaz JS; Cunha Figueiredo AC; Adegboye AR; Brito A; Mokhtar R; Allen LH; Holick MF; Kac G
Metabolism; 2017 May; 70():85-97. PubMed ID: 28403948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
